Sage Journals: Discover world-class research

Open access

Research article

First published 2009

The Novel Vascular Disrupting Agent ANG501 Induces Cell Cycle Arrest and Enhances Endothelial Cell Sensitivity to Radiation

Shona T. Dougherty, Sean E. Walker, Peter D. Davis [...]

Cancer Growth and Metastasis

Free access

Other

First published 2009-8

MRI-Based Characterization of Vascular Disruption by 5,6-Dimethylxanthenone-Acetic Acid in Gliomas

Mukund Seshadri, Michael J Ciesielski

Journal of Cerebral Blood Flow & Metabolism

Open access

Review article

First published 2023

Exploration of Chick Embryo and Chorioallantoic Membrane on Imaging Navigated Platforms for Anticancer Pharmaceutical Evaluations

Lei Chen, Mingyuan Yuan, Xinqi Zhang [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2014-4

Contrast-enhanced ultrasound (CEUS) detects effects of vascular disrupting therapy in an experimental model of gastric cancer

Sven A. Lang, Christian Moser, Sebastian Gehmert [...]

Clinical Hemorheology and Microcirculation

Retricted access

Research article

First published 2008-03

IFN- β -Dependent Inhibition of Tumor Growth by the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA)

Zachary J. Roberts, Lai-Ming Ching, Stefanie N. Vogel

Journal of Interferon & Cytokine Research

Open access

Research article

First published 2022

Sequential Administrations of a Vascular-Disrupting Agent,High-Intensity Focused Ultrasound,and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies

Yue Li, Shuncong Wang, Lei Chen [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2025

Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis

Yan Wang, Hangcheng Xu, Qiang Sa [...]

Therapeutic Advances in Medical Oncology

Search results

The Novel Vascular Disrupting Agent ANG501 Induces Cell Cycle Arrest and Enhances Endothelial Cell Sensitivity to Radiation

MRI-Based Characterization of Vascular Disruption by 5,6-Dimethylxanthenone-Acetic Acid in Gliomas

Exploration of Chick Embryo and Chorioallantoic Membrane on Imaging Navigated Platforms for Anticancer Pharmaceutical Evaluations

Contrast-enhanced ultrasound (CEUS) detects effects of vascular disrupting therapy in an experimental model of gastric cancer

IFN- β -Dependent Inhibition of Tumor Growth by the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA)

Sequential Administrations of a Vascular-Disrupting Agent,High-Intensity Focused Ultrasound,and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies

Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis